Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.61 -0.03 (-1.83%)
At close: Sep 29, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Operating Expenses (2017 - 2026)

Updated

Chemomab Therapeutics' Operating Expenses was $2.24 million in Q2 2026, down 0.9% from $2.26 million a year earlier but up 21.1% from the prior quarter.

Analysis

Chemomab Therapeutics (CMMB) Operating Expenses (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Chemomab Therapeutics' Operating Expenses was $7.91 million through Jun 30, 2026, down 37.6% year-over-year; for FY2025, it came in at $9.57 million, down 35.1% from FY2024.

  • Operating Expenses has now declined for three consecutive years, though with a five-year compound annual growth rate of 9.9% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $14.74 million in FY2024 (-42.1%), $25.46 million in FY2023 (-10.8%), $28.53 million in FY2022 (+130.7%) and $12.37 million in FY2021 (+107.1%).
  • Quarterly Operating Expenses has moved between $1.84 million (Q3 2025) and $9.05 million (Q1 2023) over five years.
  • Compared with a year earlier, Operating Expenses has declined for 12 straight quarters, with an average decline of 27.8% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q1 2022 (growth of 213.1%); the worst was Q4 2023 (a decline of 55.5%).
  • Per Business Quant data, CMMB's Operating Expenses in the three quarters before Q2 2026 was $1.85 million (Q1 2026), $1.97 million (Q4 2025) and $1.84 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Chemomab Therapeutics 11.80 Mn 11.80 Mn - 2.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.24 Mn
Mar 31, 2026 1.85 Mn
Dec 31, 2025 1.97 Mn
Sep 30, 2025 1.84 Mn
Jun 30, 2025 2.26 Mn
Mar 31, 2025 3.49 Mn
Dec 31, 2024 3.21 Mn
Sep 30, 2024 3.71 Mn
Jun 30, 2024 3.77 Mn
Mar 31, 2024 4.05 Mn
Dec 31, 2023 3.85 Mn
Sep 30, 2023 4.37 Mn
Jun 30, 2023 8.20 Mn
Mar 31, 2023 9.05 Mn
Dec 31, 2022 8.64 Mn
Sep 30, 2022 8.32 Mn
Jun 30, 2022 6.25 Mn
Mar 31, 2022 5.32 Mn
Dec 31, 2021 5.02 Mn
Sep 30, 2021 2.89 Mn
API Access

Chemomab Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=CMMB&period=max&api_key=YOUR_API_KEY